Spots Global Cancer Trial Database for The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Official Title: The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Study ID: NCT01280825
Interventions
Study Description
Brief Summary: The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
University of Chicago Medical Center, Chicago, Illinois, United States
Contact Details
Name: Peter H O'Donnell, MD
Affiliation: University of Chicago
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
